Molecular abnormalities in lung carcinogenesis and their potential clinical implications
- 1 December 2001
- journal article
- conference paper
- Published by Elsevier in Lung Cancer
- Vol. 34, S27-S34
- https://doi.org/10.1016/s0169-5002(01)00341-5
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinomaOncogene, 1999
- Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activityOncogene, 1998
- Detection of serum factors enhancing cell mutability from lung cancer patients by application of hypermutable human RS cellsInternational Journal of Cancer, 1998
- TSG101 is not mutated in lung cancer but a shortened transcript is frequently expressed in small cell lung cancerOncogene, 1998
- Mechanisms of p16INK4A inactivation in non small-cell lung cancersOncogene, 1998
- Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancerInternational Journal of Cancer, 1998
- Advances in the analysis of chromosome alterations in human lung carcinomasCancer Genetics and Cytogenetics, 1997
- Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivityThe Journal of Pathology, 1997
- Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissectionGenes, Chromosomes and Cancer, 1996